LEXEO THERAPEUTICS ANNOUNCES POSITIVE INTERIM PHASE I/II DATA AND REGULATORY UPDATE FOR LX2020 IN PKP2 ARRHYTHMOGENIC CARDIOMYOPATHY AND REP
LEXEO THERAPEUTICS ANNOUNCES POSITIVE INTERIM PHASE I/II DATA AND REGULATORY UPDATE FOR LX2020 IN PK
LEXEO THERAPEUTICS ANNOUNCES POSITIVE INTERIM PHASE I/II DATA AND REGULATORY UPDATE FOR LX2020 IN PK